ImmunityBio, Inc. IBRX
At closeNov 11, 2026, 7:48 PM EST
After hours · Nov 11, 7:48 PM ET
- YTD
- +236.87%
- 1 year
- +211.68%
Discussion (3500)
Sign in to join the discussion
It’s a no-brainer Patrick Soon used his own money $200M and converted into 250M shares. Wow a very smart move by him. At the same time diluting the market for a cheaper buying. So selfish he wants to get all the profit once Anktiva is approved.
He is very confident it will be approved…guaranteed…
The price fall is due to dilution of 250M shares by PSS. Read the report they submitted to SEC. That this will cause the price per share to ho down significantly. Cheaper for them to shallow the remaining shares in the market
Folks this is bright boys game and PSS with his bunch of smart advisers, they will make fortune out of this. No doubt Anktiva is a success. Just a matter of time
Very smart move by PSS by just converting the 200M loan into 250M shares he already made 137M gain, right? He’s confident Anktiva will be approved by FDA
Why would PSS use his own money if he sense IBRX will fail?
A good manipulation by PSS. Once approved PSS will make billions. He diluted the market to make it cheaper when approval comes
Smart move by Soon. He converted the 200 loan into shares. Cheaper for him to acquires shares than from the market.
An indication that a good thing is brewing
Jumped to $1.57 at the close
Hope will jump to 3:57 tomorrow
At 3:58pm watch
Last minute will jump in price